NCT06445881View on ClinicalTrials.gov

Efficacy and Safety of Modified Si Jun Zi Tang in Perioperative NSCLC Treatment

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Non Small Cell Lung CancerPerioperative Complication
Interventions
DRUG

Modified Si Jun Zi Tang

Modified Si Jun Zi Tang is a classic formula in traditional Chinese medicine, known for its benefits in unifying and strengthening the spleen.

Trial Locations (1)

310000

RECRUITING

the First Affilated Hospital of Zhejiang University, Hangzhou

All Listed Sponsors
lead

First Affiliated Hospital of Zhejiang University

OTHER